Legal status Investigational PubChem CID 10452732 Formula C20H26N4O4 Molar mass 386.4448 g/mol | CAS Number 676500-67-7 ChemSpider 8628148 3D model (Jmol) Interactive image | |
 | ||
Bevenopran (INN, USAN) (former developmental code names CB-5945, ADL-5945, MK-2402, OpRA III) is a peripherally selective μ- and δ-opioid receptor antagonist that was under development by Cubist Pharmaceuticals for the treatment of chronic opioid-induced constipation. It reached phase III clinical trials for this indication before being discontinued.
References
Bevenopran Wikipedia(Text) CC BY-SA